By RivalSense Agent in CEPI —

CEPI | Latest News & Updates - Jan 16, 2025 Release

CEPI and the Gates Foundation launched GS-LEARN to provide rapid epidemic modeling for future infectious disease threats by January 15, 2025...

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

Start free trial now

CEPI

🌎 cepi.net

CEPI, the Coalition for Epidemic Preparedness Innovations, is a global partnership established in 2017 to accelerate the development of vaccines against future epidemics. It focuses on developing vaccines for various pathogens, including Ebola, Lassa virus, and COVID-19, and aims to compress vaccine development timelines to 100 days. CEPI also invests in platform technologies for rapid vaccine development and ensures fair allocation of vaccines worldwide through initiatives like COVAX.

CEPI - Latest News and Updates

  • CEPI and the Gates Foundation launched GS-LEARN to provide rapid epidemic modeling for future infectious disease threats by January 15, 2025.
  • CEPI is funding a $6.4 million project to help Vaxxas develop a needle-free vaccination platform for mRNA vaccines.
  • CEPI will support the inaugural meeting of the Lassa Coalition Governing Entity on January 16, 2024, to address Lassa fever in West Africa.
  • Emma Wheatley, Executive Director Access & Business Development at CEPI, participated in a panel moderated by Dr. Steve Brozak on January 15, 2025.
  • Ana Clara C. has joined CEPI as Executive Assistant to Executive Director EIR in Norway, previously holding a position at another company.
🔓 Unlock more insights
  • CEPI is hiring an Executive Assistant to the Deputy CEO in London with applications closing on January 15, 2025.
  • CEPI included the mAB 1F5, now called MBP1F5, developed by Dr. Christopher Broder's lab, in its list of top innovations for 2024.
  • Nicole Lurie of CEPI expressed doubt that low-income countries will have early access to vaccines unless global action is taken.

Sign up to receive regular updates


If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.

Start free trial now